MIM
AXNX icon

Monashee Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Monashee Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34,644
Closed -$2.2M – 392
2021
Q2 		$2.2M Buy
+34,644
New +$2.05M 0.26% 110

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Monashee Investment Management's AXNX Position: Q3 2021 in Review

Monashee Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2021, closing a stake of 34,644 shares — an estimated $2.2M sold.

Monashee Investment Management first reported a position in AXNX in Q2 2021 and held it in 1 quarter. The position peaked at $2.2M in Q2 2021. 187 funds tracked by Wall St. Rank hold AXNX as of Q3 2021.

  • Monashee Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 34,644 Axonics, Inc. Common Stock shares in Q3 2021, an estimated $2.2M.
  • Monashee Investment Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Monashee Investment Management's Axonics, Inc. Common Stock position peaked at $2.2M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.